Recall Register

Food, drugs, devices › InvaGen Pharmaceuticals, Inc.

Drug recall: Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of solution Total

FDA enforcement event 83117 · Class III · initiated 12 Jun 2019 · status Terminated · terminated 28 Jan 2021

DrugVoluntary: Firm initiated1 product recordCentral Islip, NY

FDA enforcement event 83117 is a drug recall by InvaGen Pharmaceuticals, Inc. of Central Islip, NY, initiated 12 Jun 2019 and classified Class III, with 1 product record.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 22% of the 362 drug enforcement events initiated in 2019 carry the same class.

Status: Terminated, terminated 28 Jan 2021. Initiation: voluntary: firm initiated. InvaGen Pharmaceuticals, Inc. has 8 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

InvaGen Pharmaceuticals, Inc., Central Islip, NY.

Reason for recall

"Defective Container; actuator may improperly function and affect dose delivery."

Distribution

"Nationwide"

Product records

Recall numberProductQuantityClassStatusReport date
D-1454-2019Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of solution Total contents: 110 mL to deliver 90 mL, Manufactured by: Cipla Ltd, Verna Goa, India Manufactured for: Cipla USA, Inc., Sunrise, FL 33323 NDC 69097-363-441776 bottlesClass IIITerminated10 Jul 2019

Context

22%of 2019 drug events are Class III362 events that year
1product record in this eventfirm median: 1
8events on this register for the firm

Other enforcement events for InvaGen Pharmaceuticals, Inc.

InitiatedProduct (first record)TypeClassRecords
17 Nov 2023Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen PharmaceuticaDrugClass I1
14 May 2020Gabapentin Tablets USP, 600 mg, Rx Only, 500-count bottle, Manufactured for: Exelan Pharmaceuticals, Inc., LawrencevilleDrugClass III1
22 Mar 2019Testosterone Cypionate Injection, USP, 2000 mg/10 mL (200 mg/mL), For intramuscular use only, 10 mL Vial, Multiple-Dose,DrugClass II3
3 Oct 2018Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, ManufDrugClass III1
6 Sep 2018Bupropion Hydrochloride ER Tablets, USP 150 mg, packaged in a) 90-count bottle (NDC 69097-875-05), Manufactured for: CipDrugClass III1
15 Mar 2018buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 60 count bottles, Rx Only, Manufactured for: Cipla USA Inc. 15DrugClass III2
5 Mar 2018Decitabine for Injection, 50mg per vial, Rx only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: CiplaDrugClass III1

All 8 events for InvaGen Pharmaceuticals, Inc.

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Defective Container; actuator may improperly function and affect dose delivery."

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 28 Jan 2021. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.